About Us

Roger holds strong leadership to develop & sustain an aggressive & profitable strategy for Stelis in its core areas. Roger is a seasoned professional in the biopharmaceutical space with rich experience in developing & executing strategies related to innovative biologics, biosimilars, CDMOs & complex injectable products. In his diverse career of 30+ years, he has held senior leadership positions in Allergan, Cytovance Biologics, KBI Biopharma, Diosynth RTP (formerly Covance Biotechnology Services) & Lonza Biologics. He has a strong track record in start-ups & entrepreneurial environments in overseeing operations, executing commercial strategies, & driving contract process development.

Before Stelis, Roger was the President, CEO & Member of the Board at Avid Bioservices, Inc., a California based publicly listed biotech R&D Company which, in his leadership, had a successful transition to a dedicated biologics CDMO with a strong financial & business performance. Roger is a Graduate in Physiology & Biochemistry from the University of Southampton, United Kingdom & has earned his PhD in Biotechnology from the University of Cambridge, United Kingdom.

Prateek heads the Process Development function at Stelis with a focus on outlining and implementing the strategy, structure, systems and processes, goals, and building strong capabilities to meet the customer needs.

His role involves establishing Process Development as an independent and sustainable Profit Centre, enhancing the income and profitability of the company by developing and offering economically attractive services.

Prateek has over 22 years of experience including international roles in leading biopharmaceutical companies and academic institutions, with significant leadership experience in the development of biomolecules for better health.

Prior to joining Stelis, he was Senior General Manager and Head of Process Science, R & D at Intas Pharmaceuticals, Ahmedabad where he was responsible for the overall technical and operational strategy for the development of cell lines and processes for the company’s biosimilar portfolio.

Prateek has completed his Ph.D. in Chemical and Biomolecular Engineering (2009), Cornell University, Ithaca, NY, USA. He is a B.Tech and M.Tech., Biochemical Engineering and Biotechnology from IIT, Delhi.

During his career, Prateek has received the Cornell University Research Fellowship (2004). He stood among the top 1.2% (approximately 100,000+ participants) in the IIT-JEE national entrance examination (1999).

Raghavendra Rao heads the Human Resource Development team at Stelis Raghu, as he likes to be called, sets the strategic agenda for HR at Stelis by bringing People to the front and center of the company’s growth plans.

Raghu has over 25+ years of core human resource experience in diverse, cross-sector domains including manufacturing, engineering, automotive, and R&D.

In his previous role, he was Vice President, HR & Head of Learning & Leadership Development with Siemens Ltd, Mumbai.

Raghu has had broad exposure to strategic HR initiatives and practices in iconic companies like Volvo, ABB, and Tata Motors and has led large-scale change interventions and people development initiatives. His past roles have prepared him to navigate a global matrix and work efficiently in different cultures.

He holds PG Diploma in Personnel Management from NIPM Bangalore along with PG Diploma in PM & IR from St Joseph’s School of Business Administration. Raghu is pursuing his Ph.D. in Management (Organizational Behaviour) from XLRI Jamshedpur.

Paresh heads the Finance & Accounts, Legal, Secretarial, and IT functions at Stelis and is an integral part of the leadership team responsible for defining and refining corporate strategy. He also serves as a key member of the Program Management Committee and leads supply chain management.

Paresh creates financial value through a range of initiatives. Some of his key areas of focus are – building finance capabilities, establishing secretarial functions, capital-expenditure allocation, strengthening traditional finance roles, pricing of products and services, risk management, and cost and productivity management across the organization.

He has also been instrumental in the introduction of new management reporting, streamlining SCM & IT functions, managing investor and board relations to help guide Stelis’ success.

A chartered accountant and a company secretary by qualification, Paresh has over 22 years of experience in multiple industries with extensive and varied experience in both manufacturing and service organizations. He has been awarded Role of Honor by CFO100 for 3 consecutive years in 2017, 2018 & 2019. He is regularly invited as an expert speaker in various industry forums and conferences.

Prior to joining Stelis, he was CFO at GVK Bio Group of Companies, a private equity-funded research and development organization having multiple BUs and operating subsidiaries in the US and Europe.

Anand leads all Research and Development activities at Stelis, providing technical guidance and leadership to the development teams engaged in the company’s biopharmaceutical business.

Anand has over 25 years of core biopharmaceutical development experience in CMC development of protein therapeutics particularly in analytical development and characterization of biological molecules.

He also gained invaluable experience in insulin development for global markets during a 19-year tenure at Biocon where he also worked on mAbs development which he continued later at Apobiologix (Subsidiary of Apotex).

Prior to joining Stelis, Anand worked as Director Sekkei Bio Pvt. Ltd. & as CMC Consultant with Kinexum LLP.

After securing a Masters in Bioprocess Technology at ICT (formerly UDCT) Mumbai, Anand completed his Ph.D. in Biotechnology from Deakin University, Australia.

Vishvesh heads Quality Management at Stelis, reimagining the role of quality in the company while driving a progressive and people-centric culture, ensuring that compliance, the robustness of processes, and efficiency are at the core of Stelis’ services and products.

Vishvesh has over 28 years of international experience in leading biopharmaceutical companies and academic institutions. He is an experienced and professional and leader in the biopharmaceutical industry with a proven and recognized track record in the areas of quality assurance, quality control, compliance, audits and compliance, regulatory affairs, analytical sciences and technology, technology transfer, partner operations, external manufacturing, environment, health and safety (EHS) and operations management.

Prior to joining Stelis, he was Vice President – Quality and Partner Operations, Biologics Division at Dr. Reddy’s Laboratories, where he was instrumental in establishing a quality function. During his tenure, her designed and rolled out an efficient Quality Management System to enable the integration of quality throughout the product lifecycle. He also leveraged the strategy deployment process (SDP) framework for designing and enabling processes for anytime audit readiness and successfully lead the biologics business unit in over 40 National and international regulatory audits.

Vishvesh attained a Ph.D. in Microbiology (University of Oklahoma, Oklahoma, USA) and a Post-Doctorate in Environmental Engineering from the University of California, Berkeley, USA.

Milan leads Stelis’ global business development efforts, helping to establish a worldwide footprint for the company’s portfolio of products.

Milan has over 25 years of experience in the biotech and pharmaceutical industry.

Prior to joining Stelis, he was Director of Business Development at Apotex and has worked for companies including Mabxience and Intas where he established a global presence for biosimilars in regulated and emerging markets. Milan has been instrumental in successfully concluding more than 70 licensing collaboration agreements covering biosimilars, biologics, and specialty pharmaceuticals across North America, Japan, China, Russia, South East Asia, Europe, and the Middle East. Before venturing into business development activities, he worked as an Engineer on a project for setting up one of the biggest IV fluid facilities.

He holds a Bachelor’s degree in Engineering and a MBA in Finance and Marketing.